Evidence map›Paper›PMID 30228955›Full record

ArticleOncoimmunology

Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma.

Laetitia Douguet, Lloyd Bod, Laura Labarthe, Renée Lengagne, Masashi Kato, Isabelle Couillin, Armelle Prévost-Blondel

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Nitration in cancer signaling.Redox biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Laetitia DouguetInstitut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.
Lloyd BodInstitut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.
Laura LabartheInstitut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.
Renée LengagneInstitut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.
Masashi KatoNagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Isabelle CouillinINEM, CNRS, UMR7355, University of Orleans, Orleans, France.
Armelle Prévost-BlondelInstitut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.ORCID 0000-0002-7268-5905
Délégation Paris 5 · FRNagoya University · JPUniversité d'Orléans · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high expression of inducible nitric oxide synthase (NOS2) by myeloid-derived suppressor cells (MDSCs) is a key mechanism of immune evasion in cancer. Recently we reported that NOS2 is also expressed by γδ T cells in melanoma, contributing to their polarization towards a pro-tumor phenotype. The molecular mechanisms underlying regulation of NOS2 expression in tumor-induced γδ T cells remain unexplored. By using the model of mice transgenic for the ret oncogene (Ret mice) that develops a spontaneous metastatic melanoma, we evidence that interleukin (IL)-1β and IL-6 drive NOS2 expression in γδ T cells. Indeed, their

Indexed as

interleukin 1βinterleukin 6melanomaNOS2pro-tumorogenic γδ T cells

Identifiers

PMID30228955
PMCPMC6140581
OpenAlexW2808215639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.